Additionally, HDFC Securities has assigned an ‘add’ rating to Max Healthcare Institute, Dr. Lal PathLabs, and Metropolis Healthcare, with price targets of ₹900, ₹2,700, and ₹2,010, respectively. The brokerage anticipates that India’s healthcare sector is on track for continuous expansion, driven by factors such as an aging population, a rise […]